ArticleCureus2025
Venous Sinus Stenting for Challenging Cases of Idiopathic Intracranial Hypertension: A Case Series From a Tertiary Care Center in Riyadh, Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure that causes headaches and visual disturbances. While medical management is the primary treatment, some patients remain refractory. Venous sinus stenting (VSS) has emerged as a potential alternative. This case series discusses the outcomes of VSS in patients with refractory IIH. Patients with IIH who underwent VSS at a tertiary hospital in Riyadh were reviewed. The data collected included demographics, clinical presentation, diagnostic imaging findings, intraprocedural pressure measurements, and clinical and radiological outcomes before and after stenting. Verbal consent was obtained from all patients for participation in this case series. All patients demonstrated transverse sinus stenosis and had persistent symptoms despite medical therapy. Following VSS, all patients experienced significant improvements in intracranial pressure gradients, papilledema grades, visual symptoms, and the frequency and intensity of headaches. No procedural complications occurred, although one patient experienced transient worsening of symptoms after the procedure. This case series suggests that VSS may be an effective treatment for carefully selected patients with refractory IIH and can lead to improvements in clinical and radiological outcomes. However, larger, prospective, controlled studies with longer follow-ups are needed to confirm these findings and establish the long-term efficacy and safety of VSS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.